ID MOLT-17 AC CVCL_2125 SY Molt-17; MOLT 17; MOLT17 DR BTO; BTO_0004174 DR CLO; CLO_0051012 DR CLDB; cl3517 DR BioSample; SAMN03472051 DR Cell_Model_Passport; SIDM00430 DR Cosmic; 933539 DR Cosmic; 1118461 DR Cosmic; 2602928 DR DSMZ; ACC-36 DR DSMZCellDive; ACC-36 DR GEO; GSM5137762 DR NCBI_Iran; C516 DR PRIDE; PXD023662 DR RCB; RCB1982 DR RCB; RCB4561 DR TKG; TKG 0385 DR Wikidata; Q54906348 RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=2784121; RX PubMed=2961573; RX PubMed=8127147; RX PubMed=8641406; RX PubMed=35354797; WW Info; RCB; -; https://cell.brc.riken.jp/en/announcement/molt-17 CC Problematic cell line: Partially contaminated. The RCB/Riken RCB1982 stock was contaminated and was replaced by RCB4561 which originates from DSMZ ACC-36. On the basis of STR profile, the version at TKG (TKG 0385) seems to be identical or closely related to the RCB1962 contaminated stock. CC Population: African American. CC Doubling time: ~50 hours (DSMZ=ACC-36). CC Omics: Proteomics; Quantitative. CC Omics: Transcriptomics; RNAseq. CC Discontinued: RCB; RCB1982; true. CC Discontinued: TKG; TKG 0385; true. CC Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. CC Cell type: T-cell; CL=CL_0000084. ST Source(s): DSMZ=ACC-36; RCB=RCB1982; TKG=TKG 0385 ST Amelogenin: X ST CSF1PO: 9,10,12 (RCB=RCB1982) ST CSF1PO: 10,12 (TKG=TKG 0385) ST CSF1PO: 11,12 (DSMZ=ACC-36) ST D13S317: 10,11,12 (RCB=RCB1982) ST D13S317: 10,12 (TKG=TKG 0385) ST D13S317: 12 (DSMZ=ACC-36) ST D16S539: 9,10 (DSMZ=ACC-36) ST D16S539: 9,14,15 (RCB=RCB1982) ST D16S539: 9,15 (TKG=TKG 0385) ST D18S51: 14,15,20 ST D19S433: 10,13 ST D21S11: 32.2,33.2 ST D2S1338: 19,21 ST D3S1358: 14,17 ST D5S818: 11,12 (DSMZ=ACC-36) ST D5S818: 12 (TKG=TKG 0385) ST D5S818: 12,13 (RCB=RCB1982) ST D7S820: 11 (TKG=TKG 0385) ST D7S820: 11,12,13 (RCB=RCB1982) ST D7S820: 12 (DSMZ=ACC-36) ST D8S1179: 14 ST FGA: 23,24 ST Penta D: 6,10 ST Penta E: 16 ST TH01: 9 (RCB=RCB1982; TKG=TKG 0385) ST TH01: 9,9.3 (DSMZ=ACC-36) ST TPOX: 8 (RCB=RCB1982; TKG=TKG 0385) ST TPOX: 8,11 (DSMZ=ACC-36) ST vWA: 16 (DSMZ=ACC-36) ST vWA: 17,18,19 (RCB=RCB1982) ST vWA: 18,19 (TKG=TKG 0385) DI NCIt; C7953; Childhood T acute lymphoblastic leukemia DI ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_1424 ! MOLT-16 SX Female AG 5Y CA Cancer cell line DT Created: 04-04-12; Last updated: 14-08-25; Version: 28 // RX PubMed=8641406; DOI=10.1111/j.1600-0609.1996.tb00721.x; RA Borgonovo-Brandter, Laura RA Heyman, Mats RA Rasool, Omid RA Liu, Yie RA Grander, Dan RA Einhorn, Stefan RT "p16INK4/p15INK4B gene inactivation is a frequent event in malignant RT T-cell lines."; RL Eur. J. Haematol. 56:313-318(1996). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=2784121; DOI=10.1002/hon.2900070203; RA Drexler, Hans Gunther RA Minowada, Jun RT "Morphological, immunophenotypical and isoenzymatic profiles of human RT leukemia cells and derived T-cell lines."; RL Hematol. Oncol. 7:115-125(1989). // RX PubMed=2961573; DOI=10.1002/eji.1830171208; RA Tighe, Lynette RA Forster, Alan RA Clark, David M. RA Boylston, Arthur W. RA Lavenir, Isabella RA Rabbitts, Terence Howard RT "Unusual forms of T cell gamma mRNA in a human T cell leukemia cell RT line: implications for gamma gene expression."; RL Eur. J. Immunol. 17:1729-1736(1987). // RX PubMed=35354797; DOI=10.1038/s41467-022-29224-5; PMCID=PMC8967900; RA Leo, Isabelle Rose RA Aswad, Luay RA Stahl, Matthias RA Kunold, Elena RA Post, Frederik RA Erkers, Tom RA Struyf, Nona RA Mermelekas, Georgios RA Joshi, Rubin Narayan RA Gracia-Villacampa, Eva RA Ostling, Paivi RA Kallioniemi, Olli-Pekka RA Pokrovskaja Tamm, Katja RA Siavelis, Ioannis RA Lehtio, Janne RA Vesterlund, Mattias RA Jafari, Rozbeh RT "Integrative multi-omics and drug response profiling of childhood RT acute lymphoblastic leukemia cell lines."; RL Nat. Commun. 13:1691.1-1691.19(2022). // RX PubMed=8127147; RA Heyman, Mats RA Grander, Dan RA Brondum-Nielsen, Karen RA Cederblad, Britta RA Liu, Yie RA Xu, Bo RA Einhorn, Stefan RT "Interferon system defects in malignant T-cells."; RL Leukemia 8:425-434(1994). //